Global Breast Cancer Diagnostic Testing Device Pipeline Assessment Report 2020 Featuring 186 Companies

Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.

"Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020". Breast Cancer Diagnostic Tests are used for detection of cancer based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Scope

• Extensive coverage of the Breast Cancer Diagnostic Tests under development

• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

• The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects

• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

• The report provides key clinical trial data of ongoing trials specific to pipeline products

• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies

• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

• Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development

• Develop market-entry and market expansion strategies

• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Breast Cancer Overview

3 Products under Development
3.1 Breast Cancer - Pipeline Products by Stage of Development
3.2 Breast Cancer - Pipeline Products by Territory
3.3 Breast Cancer - Pipeline Products by Regulatory Path
3.4 Breast Cancer - Pipeline Products by Estimated Approval Date
3.5 Breast Cancer - Ongoing Clinical Trials

4 Breast Cancer - Pipeline Products under Development by Companies
4.1 Breast Cancer Companies - Pipeline Products by Stage of Development
4.2 Breast Cancer - Pipeline Products by Stage of Development

5 Breast Cancer Companies and Product Overview

6 Breast Cancer- Recent Developments

7 Appendix

Companies Mentioned

• A&G Pharmaceutical Inc

• Abviva Inc (Inactive)

• Accelerated Medical Diagnostics LLC

• Acobiom

• Affichem SA

• AIT Austrian Institute of Technology GmbH

• Albert Ludwigs University of Freiburg

• Alere Inc

• Allarity Therapeutics A/S

• Almac Diagnostic Services Ltd

• Amarantus Bioscience Holdings Inc

• AngioGenex Inc

• Anixa Diagnostics Corporation

• Armune BioScience Inc

• Arno Therapeutics Inc

• Assurance Biosciences, Inc. (Inactive)

• Atossa Therapeutics Inc

• Aurelium BioPharma Inc.

• Autoimmune Technologies LLC

• Avant Diagnostics Inc

• Ayanda Biosystems SA (Inactive)

• BARD1 Life Sciences Ltd

• Baylor College of Medicine

• BCAL Diagnostics Pty Limited

• Becton Dickinson and Co

• Biocrates Life Sciences AG

• BioDesign Institute at Arizona State University

• Biodesix Inc

• BioGenex Laboratories Inc

• Biolidics Ltd

• BioMarCare Technologies Ltd

• BioMark Diagnostics Inc

• BioMarker Strategies LLC

• bioMerieux SA

• Biomoda Inc

• Biosceptre International Ltd

• BioSystems International

• Caprion Biosciences Inc

• Caris Life Sciences Inc

• Celcuity Inc

• Cellanyx Diagnostics, Inc.

• CellXplore, Inc.

• Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco

• Cepheid Inc

• Ceres Nanosciences Inc

• Cernostics Inc

• China Sky One Medical Inc

• Chronix Biomedical Inc

• City of Hope

• Clarient Inc

• Cleveland Diagnostics Inc.

• CompanDX Ltd

• Courtagen Life Sciences Inc

• Daan Gene Co Ltd

• Dana-Farber Cancer Institute Inc

• Dartmouth College

• Dublin City University

• Entopsis LLC

• Eurobio Scientific SA

• Exact Sciences Corp

• Exosome Diagnostics Inc

• Exosomics Siena SpA

• Fahy Gurteen UK Ltd

• Fina Biotech SL

• Fluxion Biosciences Inc

• Fournira Optime Diagnostics

• French National Institute of Health and Medical Research

• Genome Diagnostics Pvt Ltd

• GenomicTree Co Ltd

• Genoptix Inc

• George Washington University

• German Cancer Research Center

• Ghent University

• GlyCa BioSciences Inc

• GlycoZym USA Inc

• Guardant Health Inc

• H. Lee Moffitt Cancer Center & Research Institute Inc

• Hai Kang Life Corp Ltd

• Health Discovery Corp

• HealthTell Inc

• Hebrew University of Jerusalem

• Heragen Inc

• Hitachi Chemical Diagnostics Inc

• Houston Methodist Hospital

• Ikonisys Inc

• Immunovia AB

• Inanovate Inc

• Insight Genetics Inc

• Inspirata Inc

• Institute of Cancer Research

• Institute of Molecular and Translational Medicine

• IPDx Immunoprofiling Diagnostics GmbH

• IRIS International Inc

• Johns Hopkins University

• Jonakee Cancer Research, Inc.

• Kalgene Pharmaceuticals Inc

• Leica Biosystems Nussloch GmbH

• Liv Diagnostics AB

• Louisville Bioscience Inc (Inactive)

• MabCure Inc

• Matrix-Bio Inc

• MDNA Life Sciences Inc

• MDxHealth SA

• MEDITE Cancer Diagnostics Inc

• MedMira Inc

• MedPacto Inc

• Metabolomic Technologies Inc

• MetaStat Inc

• Milagen Inc

• Morphotek Inc

• MW Diagnostics Ltd

• Nanostics Inc

• NanoString Technologies Inc

• New York University

• Newcastle University

• Nonagen Bioscience Corp

• Novel Bio-spectrum Technologies Inc (Inactive)

• Nuclea Biotechnologies Inc. (Inactive)

• Nuvera Biosciences Inc

• Olink Proteomics AB

• Olympia Diagnostics Inc

• Oncimmune (USA) LLC

• OncoCyte Corp

• Onconome, Inc. (Inactive)

• OncoStem Diagnostics Pvt. Ltd

• OncoVista Innovative Therapies Inc

• Oregon Health & Science University

• OSLER Diagnostics Ltd

• OTraces Inc

• Peri Rx Inc

• Power3 Medical Products, Inc.

• Precision Biologics Inc

• Prelude Corp

• PreMD Inc (Inactive)

• Princeton University

• Proplex Technologies Llc

• Protagen AG

• Proteome Sciences Plc

• Proteomika (Inactive)

• Purdue University

• Rna Diagnostics Inc

• Roche Diagnostics Corp

• Roche Diagnostics International Ltd

• Rosetta Genomics Ltd

• RWTH Aachen University

• Savicell Diagnostic Ltd.

• Selventa Inc

• Sengenics Corp Pte Ltd

• Siemens Healthineers AG

• SomaLogic Inc

• Soricimed Biopharma Inc

• Syantra Inc

• Target Discovery Inc

• Taxor Diagnostics, LLC

• TechnoGenesys, Inc.

• The University of Nottingham

• Treos Bio Inc

• Trinity College Dublin

• Universal Diagnostics SL

• University of Alberta

• University of Bergen

• University of Bonn

• University of California San Diego

• University of Colorado

• University of Hong Kong

• University of Kansas

• University of Lyon

• University of Minnesota

• University of Missouri

• University of Nebraska

• University of Oxford

• University of Pittsburgh

• University of South Carolina

• University of South Florida

• University of Toledo

• University of Turku

• University of Wisconsin Madison

• US Biomarkers Inc

• Vala Sciences Inc

• Vermillion Inc

• Viomics Inc.

• Vitruvian Biomedical Inc

• VolitionRX Ltd

• Washington University in St Louis

• XEPTAGEN SpA

• Zetiq Technologies Ltd

For more information about this report visit https://www.researchandmarkets.com/r/amo3q4

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900